Skip to content

Application of nasal humidification rapid inflation exchange ventilation technology in pediatric airway exploration surgery under general anesthesia

Application of nasal humidification rapid inflation exchange ventilation technology in pediatric airway exploration surgery under general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080077
Enrollment
Unknown
Registered
2024-01-19
Start date
2024-01-19
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children with airway foreign bodies, new organisms in the airway, airway stenosis, pneumonia, etc.

Interventions

Group A:THRIVE+MJV ventilation management technology with a temperature of 37 degrees Celsius, oxygen flow rate of 0.2L/kg/min, and 100% oxygen concentration
Group B:THRIVE+MJV ventilation management technology with a temperature of 37 degrees Celsius, oxygen flow rate of 1L/kg/min, and 100% oxygen concentration
Group C:THRIVE+MJV ventilation management technology with a temperature of 37 degrees Celsius, oxygen flow rate of 2L/kg/min, and 100% oxygen concentration

Sponsors

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 8 Years

Inclusion criteria

Inclusion criteria: 1. Age range from 2 to 8 years old; 2. Revised pediatric ASA-PS scores ranging from I to III levels; 3. Proposed airway exploration surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Known or expected difficulty in intubation 2. Known or expected difficulty in mask ventilation 3. Oxygen dependence 4. Having congenital heart disease or respiratory developmental abnormalities 5. Contraindications to the use of neuromuscular blockade 6. Risk of reflux and aspiration 7. Individuals with a history of allergies to drugs used in anesthesia and surgery 8. Recent skull base/maxillofacial fractures 9. Patients with nasal congestion who cannot receive nasal ventilation (epistaxis/deviation of nasal septum, etc.)

Design outcomes

Primary

MeasureTime frame
Duration of SpO2 reduction to 95% after induction;

Secondary

MeasureTime frame
Minimum intraoperative blood oxygen saturation value;The highest value of intraoperative percutaneous CO2;Mean blood oxygen saturation of children during surgery;Incidence of respiratory adverse events (RAEs) after airway establishment;

Countries

China

Contacts

Public ContactHuiyan Hou

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

381935641@qq.com+86 132 6273 1499

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026